Relatives Of People with Colorectal Polyps Face Increased Risk For Colorectal Cancer

May 31, 1998

NEW YORK, NY. June 1, 1998 -- Researchers at the Columbia University College of Physicians & Surgeons have discovered that close relatives of individuals who have colon polyps (non-cancerous growths, or adenomas) face as high a risk of developing colorectal cancer as do people who have relatives with colorectal cancer itself. The research is reported in the June 1 issue of Annals of Internal Medicine.

"Our study may alter the screening approach to colorectal cancer, because it suggests that this population should get colonoscopy rather than sigmoidoscopy, which is more aggressive than previous recommendations," says Alfred I. Neugut, M.D., Ph.D., associate clinical professor of public health and medicine and co-author of the paper with Habibul Ahsan, MBBS; Gail Garbowski, MPH; Judith Jacobson, DrPH; Kenneth Forde, M.D.; Michael Treat, M.D.; and Jerome Waye, M.D.

Three tests are used to detect colorectal cancer and the polyps that often precede them -- a fecal occult blood test, sigmoidoscopy, and colonoscopy. Typically, sigmoidoscopy is used with fecal occult blood testing for screening the general population, with the more invasive colonoscopy reserved for people with a family history of colorectal cancer, who undergo it every three to five years. According to current guidelines, relatives of people with adenomas should have a yearly fecal occult blood test, with follow-up colonoscopy if results are positive. A family history of polyps or colon cancer can reflect genes that predispose to colorectal cancer, or shared dietary or other lifestyle habits that could contribute to developing the disorder.

"Over the last 20 to 30 years we have learned that by screening for colorectal cancer, both with fecal occult blood tests and sigmoidoscopy -- a flexible tube up the rectum -- we can lower mortality by 70 to 80 percent. Sigmoidoscopy screens only the distal half of the colon, so colonoscopy, which checks the entire colon, might decrease mortality further," says Dr. Neugut. But colonoscopy hasn't been more widely used because it is difficult to perform, has complications, and requires the patient to prepare for a day, he adds.

Would colonoscopy benefit people who have a relative with adenoma, rather than colorectal cancer? One previous investigation, the National Polyp Study, found that parents and siblings (first degree relatives) of people newly diagnosed with adenoma had an 80 percent increase in risk of developing colorectal cancer compared with their spouses. However, the study did not take into account the health status or family history of the spouses. Before screening recommendations can be amended to advise colonoscopy for first degree relatives of adenoma patients, the study would have to be replicated and designed to yield more specific information.

That's where the Columbia University project comes in. The researchers studied 1,554 first degree relatives of 244 patients newly diagnosed with adenoma and 2,173 relatives of 362 people who had been examined but did not have polyps. The patients were assessed between 1986 and 1988, so several years elapsed before the researchers obtained detailed information from the relatives. Results were strikingly like those of the National Polyp Study, revealing a relative risk of 1.74 for the relatives of adenoma patients. This means a slightly less than doubling of risk compared with the general population. Put a more meaningful way, the general population risk of developing colorectal cancer over a lifetime is 6 percent to 7 percent. If a person has a relative with adenoma, the risk rises to about 10 percent to 12 percent. The study also found that the risk was higher if the affected relative was diagnosed with polyps at a younger age. The relatives were not at increased risk for other types of cancer.

Dr. Neugut feels strongly that relatives of people with colon polyps should be offered colonoscopy. "The beauty of it is if you remove the adenomas, you prevent the cancer."
-end-


Columbia University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.